Literature DB >> 33285578

Psychedelics and Psychotherapy.

Sandeep Nayak1, Matthew W Johnson1.   

Abstract

Psychedelics have shown great promise in modern clinical trials for treating various psychiatric conditions. As a transdiagnostic treatment that exerts its effects through subjective experiences that leave enduring effects, it is akin to psychotherapy. To date, there has been insufficient discussion of how psychedelic therapy is similar to and different from conventional psychotherapy. In this article, we review the shared features of effective conventional psychotherapies and situate therapeutic psychedelic effects within those. We then discuss how psychedelic drug effects might amplify conventional psychotherapeutic processes-particularly via effects on meaning and relationship-as well as features that make psychedelic treatment unique. Taking into account shared features of conventional psychotherapies and unique psychedelic drug effects, we create a framework for understanding why psychedelics are likely to be effective with very diverse types of psychotherapies. We also review the formal psychotherapies that have been adjunctively included in modern psychedelic trials and extend the understanding of psychedelics as psychotherapy towards implications for clinical ethics and trial design. We aim to provide some common conceptual vocabulary that can be used to frame therapeutic psychedelic effects beyond the confines of any one specific modality. Thieme. All rights reserved.

Entities:  

Year:  2020        PMID: 33285578     DOI: 10.1055/a-1312-7297

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  7 in total

Review 1.  Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.

Authors:  Matthew W Johnson
Journal:  Curr Top Behav Neurosci       Date:  2022

2.  Restorative Retelling for Processing Psychedelic Experiences: Rationale and Case Study of Complicated Grief.

Authors:  Débora González; Marc B Aixalà; Robert A Neimeyer; Jordi Cantillo; Donald Nicolson; Magi Farré
Journal:  Front Psychol       Date:  2022-05-03

3.  Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

Authors:  Roberta Murphy; Hannes Kettner; Rick Zeifman; Bruna Giribaldi; Laura Kartner; Jonny Martell; Tim Read; Ashleigh Murphy-Beiner; Michelle Baker-Jones; David Nutt; David Erritzoe; Rosalind Watts; Robin Carhart-Harris
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

Review 4.  The Potential of Psychedelics for End of Life and Palliative Care.

Authors:  David B Yaden; Sandeep M Nayak; Natalie Gukasyan; Brian T Anderson; Roland R Griffiths
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.

Authors:  Max Wolff; Lea J Mertens; Marie Walter; Sören Enge; Ricarda Evens
Journal:  J Psychopharmacol       Date:  2022-03       Impact factor: 4.153

6.  How Psychedelic-Assisted Treatment Works in the Bayesian Brain.

Authors:  Daniel Villiger
Journal:  Front Psychiatry       Date:  2022-03-08       Impact factor: 4.157

7.  How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.

Authors:  Manon van den Berg; Igor Magaraggia; Rudy Schreiber; Todd M Hillhouse; Joseph H Porter
Journal:  Psychopharmacology (Berl)       Date:  2022-03-29       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.